Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab

L Lorena Incorvaia S Sarah Scagliarini F Fernando Sabino Marques Monteiro H Hideki Takeshita J Jose Carlos Tapia M María Natalia Gandur Quiroga E Elaine Lam D Deniz Tural L Lazar Popovic S Saul Campos-Gomez P Paolo Andrea Zucali A Augusto Mota C Cinzia Ortega J Juan Pablo Sade M Mimma Rizzo O Ondrej Fiala N Nuno Vau P Patrizia Giannatempo H Halima Abahssain A Andrea Benedetto Galosi G Giuseppe Badalamenti J Jindrich Kopecky A Aristotelis Bamias (Second Propaedeutic Department of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens) J Johannes Landmesser J Jawaher Ansari F Fabio Calabrò F Francesco Massari S Sebastiano Buti J Joaquim Bellmunt (Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA) M Matteo Santoni

Article Details

Volume / Issue Vol. 15, Issue 1
Published March 14, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (30)

L

Lorena Incorvaia

S

Sarah Scagliarini

F

Fernando Sabino Marques Monteiro

H

Hideki Takeshita

J

Jose Carlos Tapia

M

María Natalia Gandur Quiroga

E

Elaine Lam

D

Deniz Tural

L

Lazar Popovic

S

Saul Campos-Gomez

P

Paolo Andrea Zucali

A

Augusto Mota

C

Cinzia Ortega

J

Juan Pablo Sade

M

Mimma Rizzo

O

Ondrej Fiala

N

Nuno Vau

P

Patrizia Giannatempo

H

Halima Abahssain

A

Andrea Benedetto Galosi

G

Giuseppe Badalamenti

J

Jindrich Kopecky

A

Aristotelis Bamias

Second Propaedeutic Department of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens

J

Johannes Landmesser

J

Jawaher Ansari

F

Fabio Calabrò

F

Francesco Massari

S

Sebastiano Buti

J

Joaquim Bellmunt

Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

M

Matteo Santoni